Viridian Therapeutics, Inc. (FRA:1S1)

Viridian Therapeutics Revenue

Viridian Therapeutics had revenue of $70.57M USD in the quarter ending September 30, 2025, with 81,958.14% growth. This brings the company's revenue in the last twelve months to $789.00K, up 161.26% year-over-year. In the year 2024, Viridian Therapeutics had annual revenue of $302.00K, down -3.82%.

• Revenue (ttm): $789.00K
• Revenue Growth: +161.26%
• P/S Ratio: 43.18
• Revenue / Employee: $5.52K
• Employees: 143
• Market Cap: 2.61B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	302.00K	-12.00K	-3.82%
Dec 31, 2023	314.00K	-1.46M	-82.28%
Dec 31, 2022	1.77M	-1.19M	-40.20%
Dec 31, 2021	2.96M	1.91M	182.19%
Dec 31, 2020	1.05M	-3.41M	-76.46%
Dec 31, 2019	4.46M	-3.93M	-46.80%
Dec 31, 2018	8.39M	4.38M	109.49%
Dec 31, 2017	4.00M	526.00K	15.13%
Dec 31, 2016	3.48M	939.00K	37.00%
Dec 31, 2015	2.54M	-1.78M	-41.25%
Dec 31, 2014	4.32M	4.00K	0.09%
Dec 31, 2013	4.32M	-90.04K	-2.04%
Dec 31, 2012	4.41M	2.49M	130.01%
Dec 31, 2011	1.92M	-	-